Exponent, Inc. (EXPO) Stock Analysis
Recovery setup
Industrials · Engineering & Construction
Hold if already holding. Not a fresh buy at $57.34, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -2.5%/30d (confirmed downtrend).
Our interdisciplinary team of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines to solve the most pressing and complicated challenges facing stakeholders today. The firm leverages over 55 years of experience in analyzing... Read more
Hold if already holding. Not a fresh buy at $57.34, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -2.5%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 52. Maintain position. Not compelling to add more. Score 5.6/10, moderate confidence.
Passes 8/11 gates (positive momentum, favorable risk/reward ratio, clean insider activity, positive momentum, news events none recent, earnings proximity 44d clear, semi cycle peak clear, materials cycle peak clear). Suitability: aggressive.
Recent developments
updated 2026-06-17Recent Developments — Exponent, Inc.
Latest news
- NEWS Exponent (EXPO) Q3 Earnings and Revenues Top Estimates - MSN — MSN positive
- NEWS Exponent (EXPO) Reports Earnings Tomorrow: What To Expect - StockStory — StockStory neutral
- NEWS Exponent (EXPO) Reports Earnings Tomorrow: What To Expect - FinancialContent — FinancialContent neutral
- NEWS Licensing Expo 2026 Champions Sustainability, Inclusivity, and Social Good - markets.businessinsider.com — markets.businessinsider.com positive
- NEWS Canada Fisheries Minister Joanne Thompson touts Northern cod recovery at Seafood Expo Global - SeafoodSource — SeafoodSource positive
Generated 2026-06-17T08:56:47Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Material Events(8-K, last 90d)
- 2026-04-06Item 5.02MEDIUM. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.** Appointment of John D. Pye, Ph.D. On April 6, 2026, Exponent, Inc.'s (the "Company") board of directors (the "Board") appointed Dr.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
1 floor-breaker
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Analyst Consensus
Earnings
Verdict History
Frequently Asked Questions
Hold if already holding. Not a fresh buy at $57.34, but acceptable to hold if already in. Reason: Below 200-MA, MA slope -2.5%/30d (confirmed downtrend). Chart setup: Death cross but MACD improving, RSI 52. Maintain position. Not compelling to add more. Target $69.42 (+21.1%), stop $53.33 (−7.5%), A.R:R 2.9:1. Score 5.6/10, moderate confidence.
Take-profit target: $69.42 (+21.1% upside). Target $69.42 (+21.1%), stop $53.33 (−7.5%), A.R:R 2.9:1. Stop-loss: $53.33.
Below 200-MA, MA slope -2.5%/30d (confirmed downtrend).
Exponent, Inc. trades at a P/E of 26.7 (forward 20.7). TrendMatrix value score: 5.3/10. Verdict: Hold.
10 analysts cover EXPO with a consensus score of 4.1/5. Average price target: $82.
What does Exponent, Inc. do?Our interdisciplinary team of scientists, physicians, engineers, and business consultants draws from more than 90...
Our interdisciplinary team of scientists, physicians, engineers, and business consultants draws from more than 90 technical disciplines to solve the most pressing and complicated challenges facing stakeholders today. The firm leverages over 55 years of experience in analyzing accidents and failures to advise clients as they innovate their technologically complex products and processes, ensure the safety and health of their users, and address the challenges o